CVS Health Executive Says 2024 Adjusted EPS Target Of $9 Is No Longer A Reasonable Starting Point For Guidance Range
Portfolio Pulse from Benzinga Newsdesk
CVS Health's executive has stated that the previously set 2024 adjusted EPS target of $9 is no longer a reasonable starting point for guidance range.
August 04, 2023 | 11:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CVS Health's 2024 adjusted EPS target revision could potentially impact investor sentiment and the company's stock price.
The revision of CVS Health's 2024 adjusted EPS target indicates a potential change in the company's financial outlook. This could lead to a change in investor sentiment, potentially causing a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100